Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sialylated fetuin-A as a marker of immunotherapy efficacy

Sialylated fetuin-A as a marker of immunotherapy efficacy

US Patent 10884002 · Granted Jan 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of modifying a naturally occurring cannabis raw plant material, a purifi2025
Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associat2024
Cannabis products modified by removing volatile organic compounds and adding vol2022
Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids2021
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen im2021
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen im2021
IL-10 as a predictive biomarker of responsiveness to house dust mite allergen im2021
Markers of immune response2021
Markers of immune response2021
Markers of immune response2021
Cannabis products modified by removing volatile organic compounds and adding vol2020
Cannabis products modified by removing volatile organic compounds and adding vol2020